Top Core and Group Health Stories
Weight-loss drug costs will level off by 2030, Milliman predicts
By Allison BellEmployer costs for GLP-1 agonists and similar drugs could end up averaging $3.17 to $22.88 per enrollee per month.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
Employer costs for GLP-1 agonists and similar drugs could end up averaging $3.17 to $22.88 per enrollee per month.